Shares of Boston Scientific Corp. BSX shed 4.27% to $92.64 Thursday, on what proved to be an all-around dismal trading ...

Boston Scientific is Thursday's IBD Stock Of The Day as the medtech trades just below all-time highs it hit late last month. Meanwhile, analysts are raising BSX price targets with eyes on 2025. Boston ...

FactSet's Q2 sales rose 4.5% YoY to $570.66M, surpassing estimates, driven by client growth and organic revenue gains. FactSet raised its FY25 revenue forecast to $2.305B-$2.325B, with strong ...

FactSet Research (FDS) came out with quarterly earnings of $4.28 per share, beating the Zacks Consensus Estimate of $4.19 per share. This compares to earnings of $4.22 per share a year ago.

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

March 20 (Reuters) - FactSet (FDS.N), opens new tab beat analysts' estimate for second-quarter profit on Thursday, as robust demand for its financial data and analytics services drove subscription ...

FactSet exited the quarter with cash and equivalents worth $278.54 million. The company’s long-term debt expanded to $1.472 billion at the end of the quarter from $1.241 billion as of August 31 ...